⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ARMP News
Armata Pharmaceuticals, Inc. Common Stock
Form 8-K
sec.gov
ARMP
Form 8-K
sec.gov
ARMP
Armata Pharmaceuticals Achieves Key Progress Across Clinical, Regulatory and Manufacturing Activities Supporting Planned Phase 3 Initiation of AP-SA02
prnewswire.com
ARMP
Form 8-K
sec.gov
ARMP
Armata Pharmaceuticals Receives Agreement from FDA on Initial Pediatric Study Plan for AP-SA02 for the Treatment of Complicated Staphylococcus aureus Bacteremia
prnewswire.com
ARMP
Form 8-K/A
sec.gov
ARMP
Form 8-K
sec.gov
ARMP
Armata Pharmaceuticals Receives $2.5 Million of Additional Non-Dilutive Award Funding from the U.S. Department of Defense to Support AP-SA02
prnewswire.com
ARMP
Form 8-K
sec.gov
ARMP
Form 8-K
sec.gov
ARMP